X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3184) 3184
Publication (398) 398
Newsletter (331) 331
Book Review (303) 303
Conference Proceeding (4) 4
Web Resource (2) 2
Book Chapter (1) 1
Journal / eJournal (1) 1
Newspaper Article (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (2769) 2769
humans (2147) 2147
rifampin (1885) 1885
male (1386) 1386
pharmacology & pharmacy (1372) 1372
female (1129) 1129
adult (992) 992
tuberculosis (938) 938
pharmacokinetics (918) 918
rifampin - pharmacology (870) 870
rifampin - pharmacokinetics (750) 750
rifampin - administration & dosage (740) 740
animals (735) 735
drug interactions (713) 713
microbiology (668) 668
middle aged (644) 644
infectious diseases (632) 632
rifampicin (619) 619
rifampin - therapeutic use (585) 585
research (432) 432
drug therapy, combination (405) 405
tuberculosis - drug therapy (404) 404
analysis (349) 349
drug therapy (346) 346
antitubercular agents - pharmacokinetics (343) 343
pharmacology (340) 340
antitubercular agents - therapeutic use (338) 338
drugs (322) 322
area under curve (319) 319
microbial sensitivity tests (311) 311
antibiotics (307) 307
antitubercular agents - administration & dosage (299) 299
pulmonary tuberculosis (295) 295
pyrazinamide (286) 286
treatment outcome (286) 286
mice (284) 284
rifampin - blood (284) 284
tuberculosis, pulmonary - drug therapy (284) 284
aged (282) 282
abridged index medicus (272) 272
metabolism (261) 261
administration, oral (259) 259
adolescent (256) 256
mycobacterium tuberculosis - drug effects (247) 247
young adult (242) 242
dose-response relationship, drug (237) 237
mycobacterium-tuberculosis (237) 237
in-vitro (231) 231
anti-bacterial agents - pharmacology (230) 230
antibiotics, antitubercular - pharmacokinetics (226) 226
respiratory system (226) 226
dosage and administration (223) 223
isoniazid (223) 223
health aspects (219) 219
therapy (215) 215
rats (209) 209
care and treatment (203) 203
rifampin - adverse effects (201) 201
half-life (199) 199
biological availability (197) 197
antibiotics, antitubercular - administration & dosage (196) 196
drug resistance (196) 196
time factors (196) 196
anti-bacterial agents - therapeutic use (192) 192
isoniazid - pharmacokinetics (189) 189
immunology (186) 186
p-glycoprotein (186) 186
cytochrome p-450 (182) 182
infections (179) 179
kinetics (178) 178
isoniazid - therapeutic use (177) 177
bioavailability (176) 176
drug administration schedule (175) 175
hiv (175) 175
isoniazid - administration & dosage (175) 175
induction (174) 174
cross-over studies (171) 171
antitubercular agents - pharmacology (169) 169
ethambutol (166) 166
medical research (162) 162
hiv infections - drug therapy (161) 161
chemotherapy (160) 160
infection (151) 151
rifampin - analogs & derivatives (144) 144
antibiotics, antitubercular - therapeutic use (143) 143
pharmacodynamics (143) 143
antibiotics, antitubercular - pharmacology (140) 140
drug combinations (138) 138
moxifloxacin (136) 136
medicine, experimental (134) 134
research article (131) 131
rifampin - metabolism (129) 129
physiological aspects (128) 128
anti-bacterial agents - administration & dosage (127) 127
drug resistance in microorganisms (126) 126
medicine (125) 125
staphylococcal infections - drug therapy (125) 125
drug dosages (124) 124
hiv infections - complications (123) 123
pharmacology/toxicology (122) 122
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3399) 3399
Russian (40) 40
German (18) 18
French (16) 16
Chinese (12) 12
Japanese (12) 12
Italian (9) 9
Spanish (6) 6
Portuguese (4) 4
Dutch (2) 2
Korean (2) 2
Polish (2) 2
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical Infectious Diseases, ISSN 1058-4838, 6/2009, Volume 48, Issue 12, pp. 1685 - 1694
Journal Article
Biopharmaceutics & Drug Disposition, ISSN 0142-2782, 01/2018, Volume 39, Issue 1, pp. 3 - 17
In recent years, physiologically based PharmacoKinetic (PBPK) modeling has received growing interest as a useful tool for the assessment of drug... 
PBPK | drug‐drug interactions | physiologically‐based pharmacokinetic modeling | cytochrome P450 | Simcyp | drug-drug interactions | physiologically-based pharmacokinetic modeling | SYSTEMIC ANTIMYCOTICS KETOCONAZOLE | THEOPHYLLINE PHARMACOKINETICS | INCREASES PLASMA-CONCENTRATIONS | ITRACONAZOLE | HEPATIC CYP3A | DOSE PHARMACOKINETICS | ORAL MIDAZOLAM | CYTOCHROME-P450 3A ACTIVITY | PHARMACOLOGY & PHARMACY | IN-VIVO PROBE | HUMAN-POPULATIONS | Paroxetine - pharmacokinetics | Rifampin - pharmacokinetics | Cytochrome P-450 CYP2D6 Inhibitors - pharmacokinetics | Humans | Ketoconazole - pharmacokinetics | Cytochrome P-450 CYP3A Inhibitors - pharmacokinetics | Ciprofloxacin - pharmacokinetics | Fluconazole - pharmacokinetics | Drug Interactions | Cytochrome P-450 Enzyme Inducers - pharmacokinetics | Itraconazole - pharmacokinetics | Models, Biological | Computer Simulation | Quinidine - pharmacokinetics | Clarithromycin - pharmacokinetics | Software | Paroxetine | Usage | Drug interactions | Antifungal agents | Cytochrome P-450 | Ciprofloxacin | Rifampin | Genetic polymorphisms | Cytochrome | Competition | Clarithromycin | Fluconazole | Ketoconazole | Cytochrome P450 | Pharmacology | CYP1A2 protein | Minority & ethnic groups | Modulators | Computer programs | Inhibitors | Quinidine | Mathematical models | Pharmacokinetics | CYP2D6 protein | Itraconazole | Index Medicus
Journal Article
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 09/2012, Volume 56, Issue 9, pp. 4793 - 4799
Journal Article
Journal Article
The Journal of Clinical Pharmacology, ISSN 0091-2700, 09/2015, Volume 55, Issue 9, pp. 1012 - 1023
Cabozantinib is a small-molecule tyrosine kinase inhibitor that has been approved for the treatment of patients with progressive, metastatic medullary thyroid... 
pharmacokinetics | CYP2C8 | drug–drug interaction | CYP3A4 | cabozantinib | drug-drug interaction | XL184 | ERYTHROMYCIN | SUNITINIB | PHARMACOLOGY & PHARMACY | SORAFENIB | 6-BETA-HYDROXYCORTISOL | Rifampin - pharmacokinetics | Area Under Curve | Ketoconazole - administration & dosage | Humans | Microsomes, Liver - metabolism | Half-Life | Pyridines - pharmacokinetics | Cytochrome P-450 CYP3A Inhibitors - pharmacokinetics | Anilides - pharmacokinetics | Antineoplastic Agents - administration & dosage | Thiazolidinediones - pharmacokinetics | Hypoglycemic Agents - blood | Drug Interactions | Cytochrome P-450 CYP3A Inducers - pharmacokinetics | Receptor Protein-Tyrosine Kinases - antagonists & inhibitors | Antineoplastic Agents - pharmacokinetics | Microsomes, Liver - enzymology | Cytochrome P-450 CYP2C8 - metabolism | Rifampin - administration & dosage | Hypoglycemic Agents - pharmacokinetics | Pyridines - administration & dosage | Cytochrome P-450 CYP3A Inhibitors - blood | Ketoconazole - pharmacokinetics | Anilides - blood | Cytochrome P-450 CYP3A Inducers - administration & dosage | Pyridines - blood | Anilides - administration & dosage | Antineoplastic Agents - blood | Thiazolidinediones - blood | Dosage and administration | Ketoconazole | Pharmacokinetics | Rifampin | Analysis | Drug interactions | Plasma | Index Medicus
Journal Article
Clinical Drug Investigation, ISSN 1173-2563, 10/2013, Volume 33, Issue 10, pp. 727 - 736
Journal Article
Journal Article
Clinical Pharmacology & Therapeutics, ISSN 0009-9236, 04/2018, Volume 103, Issue 4, pp. 674 - 683
Journal Article
The Journal of Clinical Pharmacology, ISSN 0091-2700, 11/2016, Volume 56, Issue 11, pp. 1335 - 1343
Journal Article
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 07/2011, Volume 55, Issue 7, pp. 3244 - 3253
OA  Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley...